Celltech Regains Drug Rights from Pfizer
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 43 (Table of Contents)
Published: 4 Jan-2004
DOI: 10.3833/pdr.v2004.i43.835 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Celltech entered into a collaboration agreement with Pfizer concerning the termination of development of the rheumatoid arthritis (RA) antibody-based drug, CDP-870...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS